Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Identification of a novel crizotinib-sensitive BCL11A-ALK gene fusion in a nonsmall cell lung cancer patient.

× No keyword cloud information.

9 in total

1. Clinicopathological Features of ALK Expression in 9889 Cases of Non-small-Cell Lung Cancer and Genomic Rearrangements Identified by Capture-Based Next-Generation Sequencing: A Chinese Retrospective Analysis.

Authors: Ruiying Zhao; Jie Zhang; Yuchen Han; Jinchen Shao; Lei Zhu; Chan Xiang; Qing Zhang; Haohua Teng; Gang Qin; Lanxiang Zhao; Min Ye; Jikai Zhao; Wenjie Ding
Journal: Mol Diagn Ther Date: 2019-06 Impact factor: 4.074

Review 2. Interstitial Deletions Generating Fusion Genes.

Authors: Ioannis Panagopoulos; Sverre Heim
Journal: Cancer Genomics Proteomics Date: 2021 May-Jun Impact factor: 4.069

Review 3. Anaplastic Lymphoma Kinase (ALK) Receptor Tyrosine Kinase: A Catalytic Receptor with Many Faces.

Authors: Hao Huang
Journal: Int J Mol Sci Date: 2018-11-02 Impact factor: 5.923

4. Identification of a Novel SLC8A1-ALK Fusion and Non-Canonical Expression Significantly Responding to ALK-TKIs in Lung Adenocarcinoma: A Case Report.

Authors: Xingyu Zhu; Yuqi He; Yin Wang; Yan Lei; Xiaoxing Su; Yifan Liu; Shuangxiu Wu; Zhengfu He
Journal: Onco Targets Ther Date: 2021-09-27 Impact factor: 4.147

5. Novel read-through fusion transcript Bcl2l2-Pabpn1 in glioblastoma cells.

Authors: Lin Zhang; Dan Wang; Xiao Han; Xiaoxiao Guo; Yuanyuan Cao; Ying Xia; Dianshuai Gao
Journal: J Cell Mol Med Date: 2022-07-27 Impact factor: 5.295

Review 6. ALK-rearrangement in non-small-cell lung cancer (NSCLC).

Authors: Xue Du; Yun Shao; Hai-Feng Qin; Yan-Hong Tai; Hong-Jun Gao
Journal: Thorac Cancer Date: 2018-02-28 Impact factor: 3.500

7. 5'/ 3' imbalance strategy to detect ALK fusion genes in circulating tumor RNA from patients with non-small cell lung cancer.

Authors: Yongqing Tong; Zhijun Zhao; Bei Liu; Anyu Bao; Hongyun Zheng; Jian Gu; Mary McGrath; Ying Xia; Bihua Tan; Chunhua Song; Yan Li
Journal: J Exp Clin Cancer Res Date: 2018-03-27

8. CMTR1-ALK: an ALK fusion in a patient with no response to ALK inhibitor crizotinib.

Authors: Xue Du; Yun Shao; Hongjun Gao; Xueli Zhang; Han Zhang; Yi Ban; Haifeng Qin; Yanhong Tai
Journal: Cancer Biol Ther Date: 2018-10-01 Impact factor: 4.742

9. BCL11A: a potential diagnostic biomarker and therapeutic target in human diseases.

Authors: Jiawei Yin; Xiaoli Xie; Yufu Ye; Lijuan Wang; Fengyuan Che
Journal: Biosci Rep Date: 2019-11-29 Impact factor: 3.840

9 in total